Daqing Huake Co Ltd
Daqing Huake Co Ltd is a chemical manufacturing company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and commercial customers.
Business. Daqing Huake Co Ltd (000985.SZ) is a Chinese company operating in the commodity chemicals industry within the broader chemicals sector. The firm is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Daqing Huake Company Ltd (000985.SZ) has been formally classified within the Chemicals activity and Basic Materials economic sector, marking a significant structural update to its corporate profile. This taxonomy classification, identified as a medium-severity change, establishes the company’s operational identity within the broader industrial landscape, providing a clearer framework for sector-specific analysis and peer comparison. Concurrently, the company’s risk assessment profile has been initialized with low ratings for both dilution risk and liquidity risk. These new fields, classified as low severity, indicate that current metrics suggest minimal threat from share dilution and adequate liquidity conditions, offering a baseline for financial stability monitoring. The establishment of these fundamental classifications and risk metrics is particularly notable given the company’s limited external coverage. With only one analyst tracking the stock and no reported index memberships or top holders, the formalization of its sector identity and risk parameters provides essential data points for investors navigating a less transparent information environment. This synthesis of sector classification and risk assessment creates a more defined investment thesis for Daqing Huake. By anchoring the company in the Basic Materials sector while confirming low immediate risks in dilution and liquidity, stakeholders now have a structured basis for evaluating its performance against industry peers, despite the absence of broader market signals or cross-source validation.
Signals & dispatch
Composite-score breakdown
Synthesis
Daqing Huake Co Ltd (000985.SZ) is a Chinese company operating in the commodity chemicals industry within the broader chemicals sector. The firm is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
The company's capital structure is characterized by a strong equity base, with total equity of 590,136,620 CNY and no long-term debt, resulting in a debt-to-equity ratio of 0.0. The liquidity position is robust, as evidenced by a current ratio of 5.64, indicating the company has more than five times the current assets to cover its current liabilities. The price-to-book ratio of 3.84 suggests the market values the company at a premium to its book value, while the price-to-earnings ratio of 521.24 indicates a high valuation relative to earnings.
Profitability metrics show a return on equity (ROE) of 0.74% and a return on assets (ROA) of 0.61%, both of which are below the typical thresholds for high-performing companies in the Commodity Chemicals industry. The net income of 4,347,540 CNY is relatively low compared to the company's revenue of 484,850,360 CNY, indicating thin profit margins. The operating income of 5,786,290 CNY and gross profit of 29,599,290 CNY further highlight the company's limited profitability.
The company's revenue is not segmented by geographic region or product line in the available data, making it difficult to assess geographic or product concentration risk. However, the absence of disclosed geographic diversification suggests potential exposure to regional economic or regulatory risks. The company's operations are likely concentrated in China, given the local listing and the lack of international revenue breakdown.
The company's growth trajectory is not clearly defined in the available data, as there are no forward-looking revenue projections or historical growth rates provided. The operating cash flow of 64,832,510 CNY and capital expenditure of -11,900,500 CNY suggest the company is generating positive cash flow but is not currently investing heavily in new projects or expansion. The absence of a clear growth strategy or capital allocation plan may limit the company's long-term potential.
Risk factors for the company are currently low, with no immediate liquidity or dilution flags detected. The company has no long-term debt, and the number of shares outstanding has not changed between basic and diluted shares, indicating no near-term dilution risk. However, the low ROE and ROA suggest operational inefficiencies or weak pricing power, which could pose long-term risks to profitability. The company's reliance on a single business model without diversification may also increase vulnerability to market fluctuations.
Recent events and disclosures do not include any significant filings or transcripts that would indicate major changes in the company's operations or strategy. The last actual EPS was reported at -0.02 CNY, and the last actual revenue was 1,690,168,980 CNY, both of which are below the company's full-year revenue of 484,850,360 CNY. This discrepancy may indicate seasonal variations or reporting inconsistencies that warrant further investigation.
Daqing Huake Company Ltd (000985.SZ) has been formally classified within the Chemicals activity and Basic Materials economic sector, marking a significant structural update to its corporate profile. This taxonomy classification, identified as a medium-severity change, establishes the company’s operational identity within the broader industrial landscape, providing a clearer framework for sector-specific analysis and peer comparison. Concurrently, the company’s risk assessment profile has been initialized with low ratings for both dilution risk and liquidity risk. These new fields, classified as low severity, indicate that current metrics suggest minimal threat from share dilution and adequate liquidity conditions, offering a baseline for financial stability monitoring. The establishment of these fundamental classifications and risk metrics is particularly notable given the company’s limited external coverage. With only one analyst tracking the stock and no reported index memberships or top holders, the formalization of its sector identity and risk parameters provides essential data points for investors navigating a less transparent information environment. This synthesis of sector classification and risk assessment creates a more defined investment thesis for Daqing Huake. By anchoring the company in the Basic Materials sector while confirming low immediate risks in dilution and liquidity, stakeholders now have a structured basis for evaluating its performance against industry peers, despite the absence of broader market signals or cross-source validation.
- The company has a strong equity base and no long-term debt, contributing to a low debt-to-equity ratio and a robust liquidity position.
- Profitability is weak, with ROE and ROA below industry norms, and net income significantly lower than revenue.
- The company's revenue is not segmented by geography or product, making it difficult to assess diversification and concentration risk.
- Growth is not clearly defined, and capital expenditures are minimal, suggesting limited investment in future expansion.
- Risk factors are currently low, with no immediate liquidity or dilution concerns, but operational inefficiencies may pose long-term challenges.
Bull / Bear case
Generated · model-assistedNet income surged 160.6% year-over-year to CNY 14.8 million, demonstrating significant recent profitability improvement.
Operating income jumped 218.8% year-over-year, indicating a substantial recovery in core operational efficiency and earnings power.
The company maintains a zero long-term debt position, providing a strong balance sheet with no interest expense burden.
Cash conversion is rated best-in-class at 14.91, significantly outperforming the cohort median of 1.1.
Net income CAGR of 18.8% over four years shows consistent long-term earnings growth trajectory.
Net margin of 0.9% significantly underperforms the industry median of 4.2%, indicating weak pricing power.
Return on equity of 0.74% is drastically lower than the cohort median of 3.61%.
Revenue declined 1.5% year-over-year, reflecting stagnation in top-line growth amidst competitive pressures.
In focus — financials by report
Revenue ¥440.7M, −12,2% YoY; Operating income −20,4% YoY.
- ▍Revenue ¥440.7M, −12,2% YoY
- ▍Operating income −20,4% YoY
- ▍Net income −20,6% YoY
- ▍Net margin 1.3%
Revenue ¥414.0M, −10,8% YoY; Operating income +76,4% YoY.
- ▍Revenue ¥414.0M, −10,8% YoY
- ▍Operating income +76,4% YoY
- ▍Net income +64,5% YoY
- ▍Net margin -1.4%
Revenue ¥472.5M, −12,1% YoY; Operating income −82,1% YoY.
- ▍Revenue ¥472.5M, −12,1% YoY
- ▍Operating income −82,1% YoY
- ▍Net income −82,0% YoY
- ▍Net margin 0.9%
Revenue ¥457.4M, −5,7% YoY; Operating income −55,4% YoY.
- ▍Revenue ¥457.4M, −5,7% YoY
- ▍Operating income −55,4% YoY
- ▍Net income −55,5% YoY
- ▍Net margin 0.4%
Revenue ¥1.85B, −6,3% YoY; Operating income −11,8% YoY.
- ▍Revenue ¥1.85B, −6,3% YoY
- ▍Operating income −11,8% YoY
- ▍Net income −49,8% YoY
- ▍Free cash flow −727,0% YoY
- ▍Net margin 0.4%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Daqing Huake Co Ltd Market data — financials · 2026-05-26
- Daqing Huake Co Ltd Market data — analyst estimates · 2026-05-26
Ownership & reference
Insider activity
Short positioning
Geographic breakdown
Intel & risk
4 tracked-field change(s) detected vs prior analysis; max severity: medium.
- Dilution risk— → lowlow
- Liquidity risk— → lowlow
- Activity— → Chemicalsmedium
- Economic sector— → Basic Materialsmedium